• Recent Publications: Selected List

    January 20, 2015

    Researchers around the world are using Partek software to make biological discoveries. To date, approximately 3,000 peer-reviewed articles using Partek software have been published.

    RNA-Seq

  • RNA-Seq Analysis Pipeline for Ion Torrent™ Data

    January 20, 2015

    Do you have RNA sequencing data from an Ion Torrent machine? Then download the Whole Transcriptome analysis pipeline for Ion Torrent and load it into your Partek Flow instance. We partnered with Ion Torrent to pinpoint the ideal analysis settings and have stored them in this pipeline to make your analysis process simple and painless.

  • Partek® Genomics Suite® Now Supports 64-bit Mac OS X Mavericks

    January 20, 2015

    We’re pleased to announce that Partek Genomics Suite now supports operating systems that use 64-bit functionality such as Mac OS X Mavericks and Yosemite. This added support will allow better speed and functionality for large-scale studies as well as offer the native look and feel of the operating system on which it runs.

  • Researchers at Queen’s University of Belfast Use Partek Software in First Steps Toward Therapies for Chronic Kidney Disease

    January 18, 2015

    Large, genome-wide quantitative evaluation of DNA methylation associated with chronic kidney disease (CKD) reveals several genes with strong biological evidence for differential methylation. RNA-Seq analysis was performed using Partek® Flow® and Partek® Genomics Suite® to confirm the functional role of differential methylation in ELMO1 and PRKAG2. Findings were validated by functional enrichment using Partek® Pathway™. These results could be the first step toward identifying epigenetic therapies for CKD. 

  • Using Partek Software in Leukemia Research

    February 3, 2014

    A study by Alexander Thompson, PhD of the Centre for Cancer Research and Cell Biology, 
Queen’s University of differential gene expression in cytogenetically normal subtype of acute myeloid leukemia cells reveals a HOX/TALE signature that may have specific prognostic value. Direct gene targeting of HOXA/PBX3 sensitizes these cells to standard chemotherapy, laying a foundation for a novel therapeutic strategy. 

  • Recent Publications: Selected List

    February 3, 2014

    Researchers around the world are using Partek software to make biological discoveries. Over 860 new peer reviewed articles using Partek software were published in 2013 for a total of more than 3,000 publications.

  • Tech Tip: Recommended Aligners by Application

    February 3, 2014

    If you've ever wondered what aligner to use for your application, then download this handy guide compiled by our technical experts. Download now.

  • Updates in Partek Software

    February 3, 2014

    Partek software supports all microarray, next generation sequencing, and qPCR platforms. Regardless of which data you are analyzing, our software will take your study from start to finish. Here are some of the latest additions to our software tools.

  • Recent Webinar Recordings

    February 3, 2014

    Take a look at these recordings to see how Partek software can help in your research. 

  • Kennedy Krieger Institute and Partek Awarded $1.8M NIH Grant

    May 22, 2013

    Partek Incorporated, in collaboration with the Kennedy Krieger Institute, has been awarded a phase II Small Business Innovation Research (SBIR) grant in the amount of $1.8M by the National Institutes of Health (NIH) to develop commercial software which will analyze human genetic changes and illuminate chromosomal abnormalities underlying conditions such as autism spectrum disorder (ASD), bipolar disorder, and schizophrenia. 

Pages